JP2025508792A5 - - Google Patents
Info
- Publication number
- JP2025508792A5 JP2025508792A5 JP2024549554A JP2024549554A JP2025508792A5 JP 2025508792 A5 JP2025508792 A5 JP 2025508792A5 JP 2024549554 A JP2024549554 A JP 2024549554A JP 2024549554 A JP2024549554 A JP 2024549554A JP 2025508792 A5 JP2025508792 A5 JP 2025508792A5
- Authority
- JP
- Japan
- Prior art keywords
- solvates
- hydrates
- well
- salt
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210160862 | 2022-02-22 | ||
| CN202210160862.5 | 2022-02-22 | ||
| PCT/CN2023/077409 WO2023160542A1 (zh) | 2022-02-22 | 2023-02-21 | 二肽基肽酶抑制剂化合物的盐及晶型 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508792A JP2025508792A (ja) | 2025-04-10 |
| JP2025508792A5 true JP2025508792A5 (enExample) | 2026-02-27 |
Family
ID=87764787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024549554A Pending JP2025508792A (ja) | 2022-02-22 | 2023-02-21 | ジペプチジルペプチダーゼ阻害化合物の塩及び結晶形態 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250188067A1 (enExample) |
| EP (1) | EP4484414A4 (enExample) |
| JP (1) | JP2025508792A (enExample) |
| KR (1) | KR20240153351A (enExample) |
| CN (1) | CN118660873A (enExample) |
| AU (1) | AU2023225835A1 (enExample) |
| CA (1) | CA3243683A1 (enExample) |
| CL (1) | CL2024002490A1 (enExample) |
| IL (1) | IL314852A (enExample) |
| MX (1) | MX2024010180A (enExample) |
| TW (1) | TW202342466A (enExample) |
| WO (1) | WO2023160542A1 (enExample) |
| ZA (1) | ZA202407225B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4484423A4 (en) * | 2022-02-22 | 2026-01-07 | Haisco Pharmaceuticals Pte Ltd | PROCESS FOR PREPARING A HETEROCYCLIC COMPOUND CONTAINING NITROGEN |
| EP4646265A1 (en) | 2023-01-06 | 2025-11-12 | Insmed Incorporated | Novel, reversible dpp1 inhibitors and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100098683A (ko) * | 2007-12-12 | 2010-09-08 | 아스트라제네카 아베 | 펩티딜 니트릴, 및 디펩티딜 펩티다제 ｉ 억제제로서의 그의 용도 |
| NO2699580T3 (enExample) * | 2014-01-24 | 2018-02-24 | ||
| CN114106005B (zh) * | 2020-08-26 | 2025-08-01 | 西藏海思科制药有限公司 | 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途 |
| RS66302B1 (sr) * | 2020-08-26 | 2025-01-31 | Haisco Pharmaceuticals Pte Ltd | Derivat nitrila koji deluje kao inhibitor dipeptidil peptidaze 1 i njegova upotreba |
| CN114591315A (zh) * | 2020-12-04 | 2022-06-07 | 瑞石生物医药有限公司 | 一种组织蛋白酶c小分子抑制剂 |
| AU2022218443B2 (en) * | 2021-02-05 | 2025-03-13 | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. | Fused ring derivatives containing 1,4-oxazepane |
-
2023
- 2023-02-21 CA CA3243683A patent/CA3243683A1/en active Pending
- 2023-02-21 AU AU2023225835A patent/AU2023225835A1/en active Pending
- 2023-02-21 IL IL314852A patent/IL314852A/en unknown
- 2023-02-21 US US18/840,826 patent/US20250188067A1/en active Pending
- 2023-02-21 WO PCT/CN2023/077409 patent/WO2023160542A1/zh not_active Ceased
- 2023-02-21 JP JP2024549554A patent/JP2025508792A/ja active Pending
- 2023-02-21 EP EP23759167.2A patent/EP4484414A4/en active Pending
- 2023-02-21 MX MX2024010180A patent/MX2024010180A/es unknown
- 2023-02-21 CN CN202380015239.3A patent/CN118660873A/zh active Pending
- 2023-02-21 KR KR1020247031067A patent/KR20240153351A/ko active Pending
- 2023-02-22 TW TW112106411A patent/TW202342466A/zh unknown
-
2024
- 2024-08-20 CL CL2024002490A patent/CL2024002490A1/es unknown
- 2024-09-20 ZA ZA2024/07225A patent/ZA202407225B/en unknown